Furthermore, the cytotoxicity of NK cells was also found to be boosted by tamoxifen, which upregulated c-erbB-2 expression in HER2/neu nonamplified BC and led to tumor cell lysis by NK cell-mediated antibody-dependent cytotoxicity (ADCC). The gene discussed is ERBB2; the disease is breast cancer.